The history of Viagra, initially marketed by copyright, presents a complex case study for investors considering the healthcare arena . Despite its early success and creation of billions in revenue , the exclusivity lapse has opened the door for competing medications, substantially eroding earnings opportunities. This transition raises concerns abou